Publications

1. Moatamed NA, Vahdatshariatpanahi S, Gjertson DW, Sachs CR, Kang Y, Ostrzega N, Huang J, Memarzadeh S. Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers.. PloS one, 2023.
2. Terry AQ, Kojima H, Sosa RA, Kaldas FM, Chin JL, Zheng Y, Naini BV, Noguchi D, Nevarez-Mejia J, Jin YP, Busuttil RW, Meyer AS, Gjertson DW, Kupiec-Weglinski JW, Reed EF. Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2023.
3. Locke AF, Hickey M, Valenzuela NM, Butler C, Sosa R, Zheng Y, Gjertson D, Reed EF, Zhang Q. Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.. Transplantation, 2023.
4. Jenkins MM, Phan Tran D, Flores EA, Kupferwasser D, Pickering H, Zheng Y, Gjertson DW, Ross TM, Schaenman JM, Miller LG, Yeaman MR, Reed EF. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants.. Frontiers in immunology, 2023.
5. Samiei A, Gjertson DW, Memarzadeh S, Konecny GE, Moatamed NA. Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors.. Diagnostic pathology, 2022.
6. Aziz N, Gjertson DW, Mimiaga MJ, Azarkman CD, Soto R, Alexopoulos N, Detels R. Long-term intra- and inter-individual biological variation of serum lipid of HIV-infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study (MACS).. Lipids in health and disease, 2022.
7. Memaran N, Onnen M, Müller C, Schwerk N, Carlens J, Borchert-Mörlins B, Bauer E, Blöte R, Sugianto RI, Zürn K, Wühl E, Warnecke G, Tudorache I, Hansen G, Gjertson DW, Schmidt BMW, Melk A. Cardiovascular Burden Is High in Pediatric Lung Transplant Recipients.. Transplantation, 2022.
8. Ahn R, Schaenman J, Qian Z, Pickering H, Groysberg V, Rossetti M, Llamas M, Hoffmann A, Gjertson D, Deng M, Bunnapradist S, Reed EF, CMV Systems Immunobiology Group. Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients.. Frontiers in immunology, 2021.
9. Pickering H, Sen S, Arakawa-Hoyt J, Ishiyama K, Sun Y, Parmar R, Ahn RS, Sunga G, Llamas M, Hoffmann A, Deng M, Bunnapradist S, Schaenman JM, Gjertson DW, Rossetti M, Lanier LL, Reed EF, CMV Systems Immunobiology Group. NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.. JCI insight, 2021.
10. Kageyama S, Kadono K, Hirao H, Nakamura K, Ito T, Gjertson DW, Sosa RA, Reed EF, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW, Zhai Y. Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury.. Transplantation, 2021.
11. Chang YL, Rossetti M, Gjertson DW, Rubbi L, Thompson M, Montoya DJ, Morselli M, Ruffin F, Hoffmann A, Pellegrini M, Fowler VG, Yeaman MR, Reed EF, with the MRSA Systems Immunology Group. Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia.. Proceedings of the National Academy of Sciences of the United States of America, 2021.
12. Kang Y, Kim TH, Gjertson DW, Cohen JG, Memarzadeh S, Moatamed NA. The uterine pathological features associated with sentinel lymph node metastasis in endometrial carcinomas.. PloS one, 2020.
13. Sosa RA, Terry AQ, Kaldas FM, Jin YP, Rossetti M, Ito T, Li F, Ahn RS, Naini BV, Groysberg VM, Zheng Y, Aziz A, Nevarez-Mejia J, Zarrinpar A, Busuttil RW, Gjertson DW, Kupiec-Weglinski JW, Reed EF. Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.. Hepatology (Baltimore, Md.), 2020.
14. Pearl MH, Chen L, ElChaki R, Elashoff D, Gjertson DW, Rossetti M, Weng PL, Zhang Q, Reed EF, Chambers ET. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.. Kidney international reports, 2020.
15. Nakamura K, Kageyama S, Kaldas FM, Hirao H, Ito T, Kadono K, Dery KJ, Kojima H, Gjertson DW, Sosa RA, Kujawski M, Busuttil RW, Reed EF, Kupiec-Weglinski JW. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury.. The Journal of clinical investigation, 2020.
16. Sosa RA, Rossetti M, Naini BV, Groysberg VM, Kaldas FM, Busuttil RW, Chang YL, Gjertson DW, Kupiec-Weglinski JW, Reed EF. Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.. Annals of surgery, 2020.
17. Butler CL, Hickey MJ, Jiang N, Zheng Y, Gjertson D, Zhang Q, Rao P, Fishbein GA, Cadeiras M, Deng MC, Banchs HL, Torre G, DeNofrio D, Eisen HJ, Kobashigawa J, Starling RC, Kfoury A, Van Bakel A, Ewald G, Balazs I, Baas AS, Cruz D, Ardehali R, Biniwale R, Kwon M, Ardehali A, Nsair A, Ray B, Reed EF. Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020.
18. Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.. Arthritis & rheumatology (Hoboken, N.J.), 2019.
19. Mba Medie F, Sharma-Kuinkel BK, Ruffin F, Chan LC, Rossetti M, Chang YL, Park LP, Bayer AS, Filler SG, Ahn R, Reed EF, Gjertson D, Yeaman MR, Fowler VG, MRSA Systems Immunobiology Group. Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.. Proceedings of the National Academy of Sciences of the United States of America, 2019.
20. Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW. Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.. BMC immunology, 2019.
21. Zhu Y, Smith DJ, Zhou Y, Li YR, Yu J, Lee D, Wang YC, Di Biase S, Wang X, Hardoy C, Ku J, Tsao T, Lin LJ, Pham AT, Moon H, McLaughlin J, Cheng D, Hollis RP, Campo-Fernandez B, Urbinati F, Wei L, Pang L, Rezek V, Berent-Maoz B, Macabali MH, Gjertson D, Wang X, Galic Z, Kitchen SG, An DS, Hu-Lieskovan S, Kaplan-Lefko PJ, De Oliveira SN, Seet CS, Larson SM, Forman SJ, Heath JR, Zack JA, Crooks GM, Radu CG, Ribas A, Kohn DB, Witte ON, Yang L. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.. Cell stem cell, 2019.
22. Melk A, Babitsch B, Borchert-Mörlins B, Claas F, Dipchand AI, Eifert S, Eiz-Vesper B, Epping J, Falk CS, Foster B, Geyer S, Gjertson D, Greer M, Haubitz M, Lau A, Maecker-Kolhoff B, Memaran N, Messner HA, Ostendorf K, Samuel U, Schmidt BMW, Tullius SG, West L, Wong G, Zimmermann T, Berenguer M. Equally Interchangeable? How Sex and Gender Affect Transplantation.. Transplantation, 2019.
23. Pearl MH, Grotts J, Rossetti M, Zhang Q, Gjertson DW, Weng P, Elashoff D, Reed EF, Tsai Chambers E. Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies.. Kidney international reports, 2018.
24. Chan LC, Rossetti M, Miller LS, Filler SG, Johnson CW, Lee HK, Wang H, Gjertson D, Fowler VG, Reed EF, Yeaman MR, MRSA Systems Immunobiology Group. Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory.. Proceedings of the National Academy of Sciences of the United States of America, 2018.
25. Zhang Q, Hickey M, Drogalis-Kim D, Zheng Y, Gjertson D, Cadeiras M, Khuu T, Baas AS, Depasquale EC, Halnon NJ, Perens G, Alejos J, Cruz D, Ali N, Shemin R, Kwon M, Fishbein MC, Ardehali A, Deng M, Reed EF. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.. Transplantation, 2018.
26. Pinelli DF, Zachary AA, Friedewald JJ, Gjertson DW, Evans MA, Chatroop EN, Leffell MS, Vo AA, Jordan SC, Montgomery RA, Tambur AR. Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018.
27. Lan JH, Gjertson D, Zheng Y, Clark S, DeKAF Investigators, Reed EF, Cecka MJ. Clinical utility of complement-dependent C3d assay in kidney recipients presenting with late allograft dysfunction.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018.
28. Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Tsai Chambers E. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.. Kidney international, 2017.
29. Schaenman JM, Korin Y, Sidwell T, Kandarian F, Harre N, Gjertson D, Lum EL, Reddy U, Huang E, Pham PT, Bunnapradist S, Danovitch GM, Veale J, Gritsch HA, Reed EF. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.. Transplantation, 2017.
30. Shaw KL, Garabedian E, Mishra S, Barman P, Davila A, Carbonaro D, Shupien S, Silvin C, Geiger S, Nowicki B, Smogorzewska EM, Brown B, Wang X, de Oliveira S, Choi Y, Ikeda A, Terrazas D, Fu PY, Yu A, Fernandez BC, Cooper AR, Engel B, Podsakoff G, Balamurugan A, Anderson S, Muul L, Jagadeesh GJ, Kapoor N, Tse J, Moore TB, Purdy K, Rishi R, Mohan K, Skoda-Smith S, Buchbinder D, Abraham RS, Scharenberg A, Yang OO, Cornetta K, Gjertson D, Hershfield M, Sokolic R, Candotti F, Kohn DB. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.. The Journal of clinical investigation, 2017.
31. Sosa RA, Zarrinpar A, Rossetti M, Lassman CR, Naini BV, Datta N, Rao P, Harre N, Zheng Y, Spreafico R, Hoffmann A, Busuttil RW, Gjertson DW, Zhai Y, Kupiec-Weglinski JW, Reed EF. Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.. JCI insight, 2016.
32. Hickey MJ, Zheng Y, Valenzuela N, Zhang Q, Krystal C, Lum E, Tsai EW, Lipshutz GS, Gritsch HA, Danovitch G, Veale J, Gjertson D, Cecka M, Reed EF. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.. Human immunology, 2016.
33. Pizzo HP, Ettenger RB, Gjertson DW, Reed EF, Zhang J, Gritsch HA, Tsai EW. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.. Pediatric nephrology (Berlin, Germany), 2016.
34. Tambur AR, Glotz D, Herrera ND, Chatroop EN, Roitberg T, Friedewald JJ, Gjertson D. Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?. Human immunology, 2016.
35. Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.. Molecular and cellular biology, 2016.
36. Aziz N, Detels R, Quint JJ, Li Q, Gjertson D, Butch AW. Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions.. Cytokine, 2016.
37. Cecka JM, Gjertson DW, Reed EF. Paul I. Terasaki, PhD, 1929-2016.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016.
38. Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.. Annals of the rheumatic diseases, 2016.
39. Biniwale R, Ross D, Iyengar A, Kwon OJ, Hunter C, Aboulhosn J, Gjertson D, Ardehali A. Lung transplantation and concomitant cardiac surgery: Is it justified?. The Journal of thoracic and cardiovascular surgery, 2015.
40. Thomas KA, Valenzuela NM, Gjertson D, Mulder A, Fishbein MC, Parry GC, Panicker S, Reed EF. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015.
41. Kwon MH, Zhang JQ, Schaenman JM, Cadeiras M, Gjertson DW, Krystal CA, Laks H, Ardehali A, Deng MC, Shemin RJ, Reed EF. Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient.. The Journal of thoracic and cardiovascular surgery, 2015.
42. Li F, Wei J, Valenzuela NM, Lai C, Zhang Q, Gjertson D, Fishbein MC, Kobashigawa JA, Deng M, Reed EF. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2014.
43. Kim HJ, Brown MS, Chong D, Gjertson DW, Lu P, Kim HJ, Coy H, Goldin JG. Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months.. Academic radiology, 2014.
44. Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, Gjertson DW, Cochran AJ, Cornetta K, Wong DJ, Kaplan-Lefko P, Hamid O, Samlowski W, Cohen PA, Daniels GA, Mukherji B, Yang L, Zack JA, Kohn DB, Heath JR, Glaspy JA, Witte ON, Baltimore D, Economou JS, Ribas A. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014.
45. Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, Lunz J, Mohanakumar T, Nickerson P, Tambur AR, Zeevi A, Heeger PS, Gjertson D. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013.
46. Romero Z, Urbinati F, Geiger S, Cooper AR, Wherley J, Kaufman ML, Hollis RP, de Assin RR, Senadheera S, Sahagian A, Jin X, Gellis A, Wang X, Gjertson D, Deoliveira S, Kempert P, Shupien S, Abdel-Azim H, Walters MC, Meiselman HJ, Wenby RB, Gruber T, Marder V, Coates TD, Kohn DB. β-globin gene transfer to human bone marrow for sickle cell disease.. The Journal of clinical investigation, 2013.
47. Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, Lunz J, Mohanakumar T, Nickerson P, Tambur AR, Zeevi A, Heeger PS, Gjertson D. Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013.
48. Blumberg JM, Gritsch HA, Reed EF, Cecka JM, Lipshutz GS, Danovitch GM, McGuire S, Gjertson DW, Veale JL. Kidney paired donation in the presence of donor-specific antibodies.. Kidney international, 2013.
49. Giannoni F, Hardee CL, Wherley J, Gschweng E, Senadheera S, Kaufman ML, Chan R, Bahner I, Gersuk V, Wang X, Gjertson D, Baltimore D, Witte ON, Economou JS, Ribas A, Kohn DB. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.. Molecular therapy : the journal of the American Society of Gene Therapy, 2013.
50. Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.. Blood, 2012.
51. Wei F, Cheng S, Korin Y, Reed EF, Gjertson D, Ho CM, Gritsch HA, Veale J. Serum creatinine detection by a conducting-polymer-based electrochemical sensor to identify allograft dysfunction.. Analytical chemistry, 2012.
52. Carbonaro DA, Jin X, Wang X, Yu XJ, Rozengurt N, Kaufman ML, Wang X, Gjertson D, Zhou Y, Blackburn MR, Kohn DB. Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction.. Blood, 2012.
53. Hsiau M, Fernandez HE, Gjertson D, Ettenger RB, Tsai EW. Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation.. Transplantation, 2011.
54. Kim HJ, Brown MS, Elashoff R, Li G, Gjertson DW, Lynch DA, Strollo DC, Kleerup E, Chong D, Shah SK, Ahmad S, Abtin F, Tashkin DP, Goldin JG. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.. European radiology, 2011.
55. Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed EF. Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.. Transplantation, 2011.
56. Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011.
57. Zhang Q, Cecka JM, Gjertson DW, Ge P, Rose ML, Patel JK, Ardehali A, Kobashigawa JA, Fishbein MC, Reed EF. HLA and MICA: targets of antibody-mediated rejection in heart transplantation.. Transplantation, 2011.
58. Yang OO, Lewis MJ, Reed EF, Gjertson DW, Kalilani-Phiri L, Mkandawire J, Helleringer S, Kohler HP. Human leukocyte antigen class I haplotypes of human immunodeficiency virus-1-infected persons on Likoma Island, Malawi.. Human immunology, 2011.
59. Busuttil RW, Lipshutz GS, Kupiec-Weglinski JW, Ponthieux S, Gjertson DW, Cheadle C, Watkins T, Ehrlich E, Katz E, Squiers EC, Rabb H, Hemmerich S. rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011.
60. Kim HG, Tashkin DP, Clements PJ, Li G, Brown MS, Elashoff R, Gjertson DW, Abtin F, Lynch DA, Strollo DC, Goldin JG. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.. Clinical and experimental rheumatology, 2010.
61. Tsai EW, Wallace WD, Gjertson DW, Reed EF, Ettenger RB. Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.. Transplantation, 2010.
62. de la Cerda F, Jimenez WA, Gjertson DW, Venick R, Tsai E, Ettenger R. Renal graft outcome after combined liver and kidney transplantation in children: UCLA and UNOS experience.. Pediatric transplantation, 2010.
63. Brown MS, Kim HJ, Abtin F, Da Costa I, Pais R, Ahmad S, Angel E, Ni C, Kleerup EC, Gjertson DW, McNitt-Gray MF, Goldin JG. Reproducibility of lung and lobar volume measurements using computed tomography.. Academic radiology, 2009.
64. Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.. Human immunology, 2009.
65. Pope WB, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel PS, Lai A, Nghiemphu P, Rahmanuddin S, Goldin J. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.. Radiology, 2009.
66. Gjertson DW, Clark BD. For an always promising transplant prediction, call ANN.. Transplantation, 2008.
67. Gill J, Madhira BR, Gjertson D, Lipshutz G, Cecka JM, Pham PT, Wilkinson A, Bunnapradist S, Danovitch GM. Transplant tourism in the United States: a single-center experience.. Clinical journal of the American Society of Nephrology : CJASN, 2008.
68. Kim HJ, Li G, Gjertson D, Elashoff R, Shah SK, Ochs R, Vasunilashorn F, Abtin F, Brown MS, Goldin JG. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.. Academic radiology, 2008.
69. Gill J, Bunnapradist S, Danovitch GM, Gjertson D, Gill JS, Cecka M. Outcomes of kidney transplantation from older living donors to older recipients.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008.
70. Yang HM, Lai CK, Gjertson DW, Baruch-Oren T, Ra SH, Watts W, Wallace WD, Shintaku P, Kobashigawa JA, Fishbein MC. Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection?. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 2008.
71. Bhakta N, Marik J, Malekzadeh M, Gjertson D, Ettenger R. Can pediatric steroid-free renal transplantation improve growth and metabolic complications?. Pediatric transplantation, 2008.
72. Levinson RD, Du Z, Luo L, Monnet D, Tabary T, Brezin AP, Zhao L, Gjertson DW, Holland GN, Reed EF, Cohen JH, Rajalingam R. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.. Genes and immunity, 2008.
73. Jindra PT, Hsueh A, Hong L, Gjertson D, Shen XD, Gao F, Dang J, Mischel PS, Baldwin WM, Fishbein MC, Kupiec-Weglinski JW, Reed EF. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts.. Journal of immunology (Baltimore, Md. : 1950), 2008.
74. Mahidhara R, Bastani S, Ross DJ, Saggar R, Lynch J, Schnickel GT, Gjertson D, Beygui R, Ardehali A. Lung transplantation in older patients?. The Journal of thoracic and cardiovascular surgery, 2007.
75. Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y, Braun J, Reed E, Gjertson D, Singh RR. TNFalpha blockade in human diseases: an overview of efficacy and safety.. Clinical immunology (Orlando, Fla.), 2007.
76. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. TNFalpha blockade in human diseases: mechanisms and future directions.. Clinical immunology (Orlando, Fla.), 2007.
77. Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing TH, Graham ML, Tsukahara E, Wang B, Gjertson D, Tan P, Forman S, Petz LD. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007.
78. Gjertson DW, Brenner CH, Baur MP, Carracedo A, Guidet F, Luque JA, Lessig R, Mayr WR, Pascali VL, Prinz M, Schneider PM, Morling N. ISFG: Recommendations on biostatistics in paternity testing.. Forensic science international. Genetics, 2007.
79. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S. Hepatitis C virus and death risk in hemodialysis patients.. Journal of the American Society of Nephrology : JASN, 2007.
80. Veale JL, Yew J, Gjertson DW, Smith CV, Singer JS, Rosenthal JT, Gritsch HA. Long-term comparative outcomes between 2 common ureteroneocystostomy techniques for renal transplantation.. The Journal of urology, 2007.
81. Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.. Transplantation, 2006.
82. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.. Immunogenetics, 2006.
83. Zeidler MR, Goldin JG, Kleerup EC, Kim HJ, Truong DA, Gjertson DW, Kennedy NJ, Newman KB, Tashkin DP, Silverman JM, Corren J. Small airways response to naturalistic cat allergen exposure in subjects with asthma.. The Journal of allergy and clinical immunology, 2006.
84. Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW, Jia J, Qian L, Wilkinson AH, Danovitch GM, Pham PT, Rosenthal JT, Lassman CR, Braun J, Reed EF, Gritsch HA. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.. Human immunology, 2006.
85. Lepin EJ, Zhang Q, Zhang X, Jindra PT, Hong LS, Ayele P, Peralta MV, Gjertson DW, Kobashigawa JA, Wallace WD, Fishbein MC, Reed EF. Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006.
86. Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.. Transplantation, 2006.
87. Futagawa Y, Terasaki PI, Waki K, Cai J, Gjertson DW. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006.
88. Kobashigawa JA, Tobis JM, Mentzer RM, Valantine HA, Bourge RC, Mehra MR, Smart FW, Miller LW, Tanaka K, Li H, Gjertson DW, Gordon RD. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006.
89. Odim J, Wheat J, Laks H, Kobashigawa J, Gjertson D, Osugi A, Mukherjee K, Saleh S. Peri-operative renal function and outcome after orthotopic heart transplantation.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006.
90. Korin YD, Lee C, Gjertson DW, Wilkinson AH, Pham TP, Danovitch GM, Gritsch HA, Reed EF. A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring.. Human immunology, 2006.
91. Sheehan R, Perloff JK, Fishbein MC, Gjertson D, Aberle DR. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome.. Circulation, 2005.
92. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005.
93. Odim J, Laks H, Allada V, Child J, Wilson S, Gjertson D. Results of aortic valve-sparing and restoration with autologous pericardial leaflet extensions in congenital heart disease.. The Annals of thoracic surgery, 2005.
94. Odim J, Laks H, Banerji A, Mukherjee K, Vincent C, Murphy C, Burch C, Gjertson D. Does duration of donor brain injury affect outcome after orthotopic pediatric heart transplantation?. The Journal of thoracic and cardiovascular surgery, 2005.
95. Mitropoulos FA, Odim J, Marelli D, Karandikar K, Gjertson D, Ardehali A, Kobashigawa J, Laks H. Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005.
96. Brown MS, Goldin JG, Rogers S, Kim HJ, Suh RD, McNitt-Gray MF, Shah SK, Truong D, Brown K, Sayre JW, Gjertson DW, Batra P, Aberle DR. Computer-aided lung nodule detection in CT: results of large-scale observer test.. Academic radiology, 2005.
97. Futagawa Y, Waki K, Gjertson DW, Terasaki PI. Living-unrelated donors yield higher graft survival rates than parental donors.. Transplantation, 2005.
98. Zhang Q, Liang LW, Gjertson DW, Lassman C, Wilkinson AH, Kendrick E, Pham PT, Danovitch GM, Gritsch HA, Reed EF. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction.. Transplantation, 2005.
99. Wenk RE, Gjertson DW, Chiafari FA, Houtz T. The specific power of parentage exclusion in a child's blood relatives.. Transfusion, 2005.
100. Gjertson DW. Revisiting the center effect.. Clinical transplants, 2005.
101. Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, Gjertson D, Rogers SR, Aberle DR. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.. Academic radiology, 2004.
102. Levinson RD, Rajalingam R, Park MS, Reed EF, Gjertson DW, Kappel PJ, See RF, Rao NA, Holland GN. Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy.. American journal of ophthalmology, 2004.
103. Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Shikowitz MJ, Gjertson DW, Reed EF. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis.. Human immunology, 2004.
104. Boedeker KL, McNitt-Gray MF, Rogers SR, Truong DA, Brown MS, Gjertson DW, Goldin JG. Emphysema: effect of reconstruction algorithm on CT imaging measures.. Radiology, 2004.
105. Troppmann C, Gjertson DW, Cecka JM, McVicar JP, Perez RV. Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004.
106. Vambutas A, Bonagura VR, Reed EF, Abramson AL, Mullooly V, DeVoti J, Gjertson DW, Steinberg BM. Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11.. The Journal of infectious diseases, 2004.
107. Gjertson DW. Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors.. Clinical transplants, 2004.
108. Kalsi JK, Grossman J, Kim J, Sieling P, Gjertson DW, Reed EF, Ebling FM, Linker-Israeli M, Hahn BH. Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.. Lupus, 2004.
109. Gjertson DW. Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002.. Clinical transplants, 2003.
110. Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, Bresson J, Gjertson D, Kobashigawa JA, UCLA Heart Tranplant Group. Use of two recipient lists for adults requiring heart transplantation.. The Journal of thoracic and cardiovascular surgery, 2003.
111. Hill JA, Goldin JG, Gjertson D, Emerick AM, Greaser LD, Yoon HC, Khorrami S, Aziz D, Adams JS. Progression of coronary artery calcification in patients taking alendronate for osteoporosis.. Academic radiology, 2002.
112. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects.. Radiology, 2002.
113. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Ardehali A, Esmailian F, Hamilton M, Fonarow GC, Moriguchi J, Plunkett M, Hage A, Tran J, Kobashigawa JA, Laks H. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2002.
114. Cecka JM, Takemoto SK, Gjertson DW. Putting one objection to HLA matching on ice.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2002.
115. Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin DP, Roth MD. A pilot study of all-trans-retinoic acid for the treatment of human emphysema.. American journal of respiratory and critical care medicine, 2002.
116. Gjertson DW. A multi-factor analysis of kidney regraft outcomes.. Clinical transplants, 2002.
117. Gjertson DW, Dabrowska DM, Cui X, Cecka JM. Four causes of cadaveric kidney transplant failure: a competing risk analysis.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2002.
118. Cai J, Gjertson DW, Terasaki P. Maintenance immunosuppressive treatment and graft half-life.. Clinical transplants, 2002.
119. Gjertson DW, Cecka JM. Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry.. Pediatric transplantation, 2001.
120. Bradley BA, Takemoto S, Gjertson D, Reed E, Cecka M. Elderly transplant recipients may require less immunosuppression.. Transplantation proceedings, 2001.
121. Gjertson DW, Cecka JM. Mortality's role in kidney transplant failures.. Transplantation proceedings, 2001.
122. Takemoto SK, Bradley BA, Gjertson DW, Cho YW, Cecka JM. Pregnancy: a two-edged sword.. Transplantation proceedings, 2001.
123. Marelli D, Tsai F, Laks H, Houston E, Bresson J, Friend L, Gjertson D, Sykes A, Ardehali A, Esmailian F, Hamilton M, Fonarow G, Moriguchi J, Plunkett M, Hage A, Brown M, Mark M, Kobashigawa J. Use of hearts transplanted from donors with atraumatic intracranial bleeds.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001.
124. Gjertson DW. Center and other factor effects in recipients of living-donor kidney transplants.. Clinical transplants, 2001.
125. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation.. The New England journal of medicine, 2000.
126. Gjertson DW, Cecka JM. Living unrelated donor kidney transplantation.. Kidney international, 2000.
127. Takemoto SK, Cecka JM, Gjertson DW. The economic implications of HLA matching in cadaveric renal transplantation.. The New England journal of medicine, 2000.
128. Takemoto SK, Cecka JM, Gjertson DW, Terasaki PI. Class I peptides involved in the indirect pathway of allorecognition.. Transplantation proceedings, 1999.
129. Cho YW, Cecka JM, Gjertson DW, Terasaki PI. Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants.. Transplantation proceedings, 1999.
130. Gjertson DW. Determinants of long-term survival of adult kidney transplants: a 1999 UNOS update.. Clinical transplants, 1999.
131. Takemoto SK, Cho YW, Gjertson DW. Transplant risks.. Clinical transplants, 1999.
132. Lee PC, Lee PH, Shaw CK, Takemoto SK, Gjertson DW, Siauw PA, Terasaki PI. HLA epitopes for kidney allocation.. Transplantation proceedings, 1998.
133. Cecka JM, Gjertson DW, Terasaki PI. Pediatric kidney transplantation utilizing living unrelated donors: anecdote or solution to the kidney shortage?. Pediatric transplantation, 1998.
134. Scantlebury V, Gjertson D, Eliasziw M, Terasaki P, Fung J, Shapiro R, Donner A, Starzl TE. Effect of HLA mismatch in African-Americans.. Transplantation, 1998.
135. Terasaki PI, Gjertson DW, Cecka JM. Paired kidney exchange is not a solution to ABO incompatibility.. Transplantation, 1998.
136. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating.. The New England journal of medicine, 1998.
137. Cook DJ, Fettouh HI, Gjertson DW, Cecka JM. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.. Clinical transplants, 1998.
138. Terasaki PI, Cecka JM, Gjertson DW. Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation.. Clinical transplants, 1998.
139. Gjertson DW. The role of death in kidney graft failure.. Clinical transplants, 1998.
140. Scantlebury V, Gjertson D, Eliasziw M, Terasaki P, Fung J, Shapiro R, Donner A, Starzl TE. Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991-1995.. Transplantation proceedings, 1997.
141. Starzl TE, Eliasziw M, Gjertson D, Terasaki PI, Fung JJ, Trucco M, Martell J, McMichael J, Scantlebury V, Shapiro R, Donner A. HLA and cross-reactive antigen group matching for cadaver kidney allocation.. Transplantation, 1997.
142. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants.. Clinical transplantation, 1997.
143. Cecka JM, Gjertson DW, Terasaki PI. Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing.. Pediatric transplantation, 1997.
144. Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L, Giralt S, Chan KW, Feig S, Territo M, Andersson B, van Besien K, Khouri I, Fischer H, Babbitt L, Ippolitti C, Schiller G, Lill M, Warkentin D, Neumann J, Petz L, Terasaki P, Champlin R. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1997.
145. Gjertson DW, Terasaki PI, Cecka JM, Takemoto S, Cho YW. Senior citizens pool for aged kidneys.. Transplantation proceedings, 1997.
146. Cho YW, Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. Should excessive height and weight differences between the kidney donor and recipient be avoided?. Transplantation proceedings, 1997.
147. Gjertson DW. Look-up survival tables for renal transplantation.. Clinical transplants, 1997.
148. Terasaki PI, Cecka JM, Gjertson DW, Cho YW. Spousal and other living renal donor transplants.. Clinical transplants, 1997.
149. Terasaki P, Cecka M, Gjertson D, Takemoto S. Allocation of cadaver kidneys.. Lancet (London, England), 1996.
150. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Fit and match hypothesis for kidney transplantation.. Transplantation, 1996.
151. Terasaki PI, Cho Y, Takemoto S, Cecka M, Gjertson D. Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival.. Transplantation proceedings, 1996.
152. Terasaki PL, Cecka JM, Gjertson DW, Takemoto S, Cho YW. Organizing a living donor pool: could the concept work?. Nephrology news & issues, 1996.
153. Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.. Clinical transplants, 1996.
154. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S, Cho YW, Yuge J. Risk rate and long-term kidney transplant survival.. Clinical transplants, 1996.
155. Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.. Transplantation, 1995.
156. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors.. The New England journal of medicine, 1995.
157. Takemoto S, Gjertson DW, Cecka JM, Terasaki PI. HLA matching for local pools using fewer HLA factors.. Transplantation proceedings, 1995.
158. Gjertson DW, Takemoto S, Cecka JM, Terasaki PI. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching.. Transplantation proceedings, 1995.
159. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Proposed HLA matching scheme for improved cadaveric kidney allocation.. Transplantation proceedings, 1995.
160. Terasaki PI, McClelland JD, Yuge J, Cecka JM, Gjertson DW, Takemoto S, Cho YW. Advances in kidney transplantation: 1985-1995.. Clinical transplants, 1995.
161. Wolf JS, Callender CO, Terasaki PI, Cecka JM, Gjertson DW, Takemoto SK. How should cadaver-donor kidneys be allocated in the United States?. Clinical transplants, 1995.
162. Amend WJ, Gjertson DW, Cecka JM. Primary disease effects and associations in patients without early posttransplant events.. Clinical transplants, 1995.
163. Katznelson S, Gjertson DW, Cecka JM. The effect of race and ethnicity on kidney allograft outcome.. Clinical transplants, 1995.
164. Gjertson DW. Two-factor reference tables for renal transplantation.. Clinical transplants, 1995.
165. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. HLA matching for improved cadaver kidney allocation.. Current opinion in nephrology and hypertension, 1994.
166. Takemoto S, Terasaki PI, Gjertson DW, Cecka JM. Equitable allocation of HLA-compatible kidneys for local pools and for minorities.. The New England journal of medicine, 1994.
167. Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation.. Transplantation, 1994.
168. Terasaki PI, Cecka JM, Gjertson DW. Current world opinion regarding the use of living donors.. Clinical transplants, 1994.
169. Terasaki PI, Yuge J, Cecka JM, Gjertson DW. Cytomegalovirus antibody status and kidney transplantation.. Clinical transplants, 1994.
170. Terasaki PI, Cecka JM, Gjertson DW. High graft survival with spousal and 2-HLA-haplotype mismatched sibling-donor transplants.. Clinical transplants, 1994.
171. Gjertson DW. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry: a 1994 update.. Clinical transplants, 1994.
172. Dawson S, Imagawa DK, Cecka JM, Gjertson DW, Shackleton CM, Shaked A, Busuttil R. UCLA liver transplantation: analysis of the first 1,000 patients.. Clinical transplants, 1994.
173. Cecka JM, Gjertson DW, Cho Y, Terasaki PI. HLA polymorphisms, ethnicity, and graft survival: united network for organ sharing. UNOS Scientific Renal Transplant Registry.. Transplantation proceedings, 1993.
174. Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients.. Transplantation, 1993.
175. Takemoto S, Cecka JM, Gjertson DW, Terasaki PI. Six-antigen-matched transplants. Causes of failure.. Transplantation, 1993.
176. Cecka JM, Gjertson D, Terasaki PI. Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?. Transplantation proceedings, 1993.
177. Gjertson DW, Terasaki PI, Cecka JM, Takemoto S. Reduction of the center effect by HLA matching.. Transplantation proceedings, 1993.
178. Gjertson DW. Center-dependent transplantation factors: an analysis of renal allografts reported to the United Network for Organ Sharing Registry.. Clinical transplants, 1993.
179. Takemoto S, Gjertson DW, Terasaki PI. HLA matching: maximizing the number of compatible transplants.. Clinical transplants, 1993.
180. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. The role of HLA typing in clinical kidney transplants: 30 years later. Indisputable fact regarding clinical organ transplantation.. Clinical transplants, 1993.
181. Terasaki PI, Yuge J, Cecka JM, Gjertson DW, Takemoto S, Cho Y. Thirty-year trends in clinical kidney transplantation.. Clinical transplants, 1993.
182. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.. The New England journal of medicine, 1992.
183. Cecka JM, Gjertson D, Terasaki PI. Superior renal allograft survival among Asian recipients.. Transplantation proceedings, 1992.
184. Gjertson DW, Terasaki PI. The large center variation in half-lives of kidney transplants.. Transplantation, 1992.
185. Terasaki PI, Cecka JM, Gjertson DW, Cho Y, Takemoto S, Cohn M. A ten-year prediction for kidney transplant survival.. Clinical transplants, 1992.
186. Takemoto S, Gjertson DW, Terasaki PI. HLA matching: a comparison of conventional and molecular approaches.. Clinical transplants, 1992.
187. Gjertson DW. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry.. Clinical transplants, 1992.
188. Gjertson DW, Terasaki PI, Takemoto S, Mickey MR. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs.. The New England journal of medicine, 1991.
189. Cho YW, Gjertson DW. Assessment of interaction among risk factors in three-month graft survival of first cadaveric renal transplantations: a case-control study.. Clinical transplants, 1991.
190. Gjertson DW. Survival trends in long-term first cadaver-donor kidney transplants.. Clinical transplants, 1991.
191. Terasaki PI, Cecka JM, Lim E, Takemoto S, Cho Y, Gjertson D, Ogura K, Koyama H, Mitsuishi Y, Yuge J. UCLA and UNOS Registries. Overview.. Clinical transplants, 1991.
192. Cho YW, Cecka JM, Gjertson DW, Terasaki PI. The UNOS Scientific Renal Transplant Registry: multistep regression models on kidney graft survival.. Clinical transplants, 1990.
193. Gjertson DW. Update: center effects.. Clinical transplants, 1990.
194. Siauw PA, Lim E, Hardy S, Tayag N, Gjertson D, Terasaki PI. Automated reading of the microcytotoxicity test.. Clinical transplants, 1989.
195. Gjertson DW. Short- and long-term effects of HLA matching.. Clinical transplants, 1989.
196. Gjertson DW, Mickey MR, Hopfield J, Takenouchi T, Terasaki PI. Calculation of probability of paternity using DNA sequences.. American journal of human genetics, 1988.
197. Gjertson DW, Mickey MR, Terasaki PI. Empirical paternity exclusion rates.. The American journal of forensic medicine and pathology, 1987.
198. Mickey MR, Gjertson DW, Terasaki PI. Empirical validation of the Essen-Möller probability of paternity.. American journal of human genetics, 1986.
199. Danilovs JA, Terasaki PI, Kuban DJ, Sparkes RS, Gjertson D, Bernoco D. Two independent HLA-B-locus specificities expressed on a single haplotype.. Transplantation proceedings, 1979.
200. Danilovs J, Terasaki PI, Gjertson D, Bernoco D. Five subtypic specificities of the Bw22 complex in four racial groups.. Transplantation proceedings, 1978.
201. Terasaki PI, Bernoco D, Gjertson D, Mickey MR, Perdue S. Ninety-five percent probability of paternity with HLA, ABO and haptoglobins.. Forensic science international, 1978.
202. Terasaki PI, Gjertson D, Bernoco D, Perdue S, Mickey MR, Bond J. Twins with two different fathers identified by HLA.. The New England journal of medicine, 1978.